ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

AJVS. 2025; 86(0): 130-135


The Role of Parapox virus (Zylexis) in Enhancing Humeral and Cellular Immune Response in Sheep Vaccinated with FMD Vaccine

Azza M. Mohamed, Mohamed H. Atwa, Eman R. Abdo, Diana M. Abul Magd.



Abstract
Download PDF Post

In this work, a trial was conducted to improve sheep reaction of the immune system to the inactivated FMD vaccination by using Zylexis as an immune-modulatory. Three groups of five sheep each were formed from the fifteen sheep. The first group received 2 injections of zylexis (2 ml/sheep, I/M) given on three days interval concurrently with vaccination with one dose of the inactivated FMD (SAT-2) vaccine (1ml/sheep, S/C); the second group got the vaccination and nothing else, while the third group served as a control and did not get any inoculation at all. To evaluate the humeral immune response, SNT and ELISA were used to serum samples, and blood samples obtained while taking heparin as an anticoagulant to assess the cellular immune response. Over the course of 40 weeks after vaccination, the findings showed that sheep given the inactivated zylexis vaccine had a stronger cellular and humoral immune response than sheep given the inactivated FMD (SAT-2) vaccine alone. In order to prolong the duration of immunity, it might be suggested to combine it with FMD vaccination. This would boost the immunological response of vaccinated animals.

Key words: FMD, SAT-2, Zylexis, SNT, ELISA,







Bibliomed Article Statistics

33
25
15
22
7
R
E
A
D
S

42

48

28

18

9
D
O
W
N
L
O
A
D
S
0708091011
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.